It is well recognised that chronic otitis media (COM) is a risk factor for sensorineural hearing loss. Studies on the effect of COM on vestibular function have been beset by design biases. The authors designed a case control study to...
We are all familiar with patients suffering extensive nasal polyps who relapse all to soon after careful and thorough endoscopic sinus surgery (ESS). This paper looks to answer whether we can predict which patients will do well, and which less...
This funded research trial involving 14 adolescents, aged 10 to 17 years, in the Toronto Hospital for Sick Kids was carried out just prior to the new Osia implant obtaining FDA approval for use in the USA. The majority had...
Idiopathic sudden sensorineural hearing loss (ISSNHL) is a rare but potentially devastating condition. For patients presenting with this condition, prognosis is of paramount importance. Wu et al begin to address this issue by retrospectively studying 17 potential prognostic factors for...
Cl-ear, the fastest growing ear care brand of drops and spray¹, welcomes Mr Neel Raithatha, Consultant Audiologist BSc (Hons), RHAD, MSHAA, The Wax Whisperer, as healthcare advisor.
Untreated reflux can cause inflammation, scarring, narrowing and precancerous changes in the oesophagus and larynx, and may increase the risk of asthma and sleep apnoea.
BIOHIT HealthCare recently filmed an exciting testimonial video with Jane Shaw, Consultant Speech and Language Therapist (SLT) at Doncaster and Bassetlaw Hospitals NHS Trust.
Voice disorders affect one in 25 people in the UK, and laryngopharyngeal reflux (LPR) is a common culprit. LPR occurs when the stomach contents – including strong digestive enzymes like pepsin – flow back up into the throat, causing inflammation...
The vexed topic of reflux always generates much discussion, particularly when it comes to testing. We hear about a non-invasive assay that is gaining in popularity. Voice disorders impact around four percent of the UK population and can significantly hamper...
Dupilumab is a humanised monoclonal antibody that targets type 2 inflammation by blocking IL-4 and IL-13 signalling. Reported adverse events from its use include injection site erythema, conjunctivitis, arthralgia and hypereosinophilia. The potential for more severe eosinophilic-related complications such as...
Middle ear cleft cholesteatoma is an inflammatory disease that erodes local bony structures and can cause otorrhea, hearing loss, vertigo and intracranial complications. It is usually treated with surgery, typically canal wall up (CWU) or canal wall down (CWD) surgery....
“I could just keep going when most sane people would stop”- the secret to success in head and neck surgery? In August 2015 I crossed the finish line of La Ultra - The High. A small camp of tents and...